Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | N-Acetyloxytocin;10551-48-1;Oxytocin, N-acetyl-;N(alpha)-Acetyloxytocin;(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-acetamido-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;N-Acetyl Oxystin;SCHEMBL16790726;HY-P3219;CS-0169709;N-Acetyl Oxystin; Oxytocin Imp. E (EP): N-Acetyloxytocin; Oxytocin, N-acetyl- (8CI, 9CI, ACI); 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv. (ZCI); Oxytocin, 1-(N-acetylcysteine) (7CI); |
M.F/Formula | C45H68N12O13S2 |
M.W/Mr. | 1049.2 |
Sequence | One Letter Code:CYIQNCPLG Three Letter Code:Ac-Cys(1)-Tyr-Ile-Gln-Asn-Cys(1)-Pro-Leu-Gly-NH2 |
InChI | InChI=1S/C45H68N12O13S2/c1-6-23(4)37-44(69)51-27(13-14-34(46)60)39(64)53-30(18-35(47)61)40(65)55-32(45(70)57-15-7-8-33(57)43(68)54-28(16-22(2)3)38(63)49-19-36(48)62)21-72-71-20-31(50-24(5)58)42(67)52-29(41(66)56-37)17-25-9-11-26(59)12-10-25/h9-12,22-23,27-33,37,59H,6-8,13-21H2,1-5H3,(H2,46,60)(H2,47,61)(H2,48,62)(H,49,63)(H,50,58)(H,51,69)(H,52,67)(H,53,64)(H,54,68)(H,55,65)(H,56,66)/t23-,27-,28-,29-,30-,31-,32-,33-,37-/m0/s1 |
InChI Key | RROMYFJBCBPTNU-RANNHORISA-N |
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.